|
ISCA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.10339998144116E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.239900E-02 |
| Stage1-vs-Stage3 |
1.799960E-02 |
| Stage1-vs-Stage4 |
1.50219999999202E-05 |
| Stage2-vs-Stage3 |
1.256160E-03 |
| Stage2-vs-Stage4 |
2.68230000000091E-06 |
| Stage3-vs-Stage4 |
1.865620E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.14350759364379E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
8.554400E-01 |
| Caucasian-vs-Asian |
8.577200E-01 |
| AfricanAmerican-vs-Asian |
8.105800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.628600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
5.97650000044858E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.737800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.754600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.949200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.568000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.858400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.981800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.14150000030922E-07 |
| Classical-VS-Follicular |
6.3703000000026E-05 |
| Classical-VS-Other |
7.214000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
8.17159673260903E-11 |
| Tall-VS-Other |
2.205400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.023600E-01 |
| Follicular-VS-Normal |
1.63802305053196E-12 |
| Other-VS-Normal |
1.97023999999324E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.34890000000632E-05 |
|
|
